Enanta Pharma (ENTA) Affirms FDA Breakthrough Therapy Designation Given to AbbVie’s HCV Regimen
Tweet Send to a Friend
Enanta Pharmaceuticals, Inc., (Nasdaq: ENTA) announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
